Navigation Links
XTENT Announces Fourth Quarter 2008 Financial Results and Business Progress
Date:2/19/2009

MENLO PARK, Calif., Feb. 19 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today reported financial results for the fourth quarter and year ended December 31, 2008 and provided an update on its business.

The company reported a net loss of $7.1 million, or $0.31 per share, for the fourth quarter of 2008, compared to a net loss of $11.9 million, or $0.52 per share, for the fourth quarter of 2007. For the year ended December 31, 2008, XTENT had a net loss of $41.1 million, compared to $38.8 million for the same period last year. As of December 31, 2008, XTENT had cash, cash equivalents and short-term investments of $19.1 million.

Research and development expenses decreased to $5.3 million in the fourth quarter of 2008 from $9.2 million for the same period in 2007, primarily due to a decrease in expenditures for personnel, prototype parts and supplies as well as consulting and services and other costs incurred for clinical trials. General and administrative expenses were $2.0 million in the fourth quarter of 2008 versus $3.4 million for the same period in 2007, primarily due to a decrease in personnel, consulting, legal, and professional expenses. Research and development expenses for the year ended December 31, 2008 totaled $31.2 million, compared to $30.9 million for the same period last year. General and administrative expenses for the year ended December 31, 2008 totaled $10.9 million compared to $11.3 million for the same period in 2007.

On January 23, XTENT announced an initiative to reduce headcount by eliminating 115 positions, representing 94% of the Company's total workforce. The reduction is expected to be completed during March 2009. The Company expects to incur approximately $1.1 to $1.2 million in expenses in connection with this initiative, all of which are expected to be cash
'/>"/>

SOURCE XTENT, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. XTENT Announces Third Quarter 2007 Financial Results
2. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
3. XTENT Announces 2007 Financial Results Conference Call
4. New study shows extent of harmful human influences on global ecosystems
5. XTENT Announces 2007 Financial Results
6. XTENT to Present at Cowen and Companys 28th Annual Health Care Conference
7. XTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention
8. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
9. XTENT Announces Second Quarter 2008 Financial Results and Business Progress
10. XTENT Announces Third Quarter 2008 Financial Results
11. APIC Covers Up Extent and Causes of Deadly C. diff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014 According to a new ... Diagnostics Market (Technologies: Very High, High, Medium, Low ... Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) ... and Forecast, 2013 - 2019", the global multiplexed ... in 2012 and is expected to grow at ...
(Date:8/20/2014)... New York, NY, August 20, 2014 Transrectal ultrasound ... cancer, but international reports have suggested that the number ... a new nationwide population-based study, Swedish researchers found that ... for a urinary tract infection within 30 days after ... hospital admissions over five years, reports The Journal ...
(Date:8/20/2014)... 2014 Ticket Down is a reliable ... FL at the Sun Life Stadium in early September. , ... when Brazil and Colombia meet at Sun Life Stadium in Miami ... teams in the world and will be a rematch of their ... will kick-off on Sept. 5 and will feature some of the ...
(Date:8/20/2014)... It’s no secret that millions of Americans ... Institute on Drug Abuse, nearly 24 million Americans are ... alarming is the fact that the total number of ... locked in a struggle with substance abuse often feel ... the newly-redesigned AbuseTreatmentCenters.net has released updated lists of ...
(Date:8/20/2014)... 20, 2014 A Missouri federal judge has ... who were treated with GranuFlo and NaturaLyte to the City ... of Baron and Budd. The judge rejected an assertion by ... they were invalid. (McGee, et al. v. Fresenius Medical Care ... Fresenius Medical Care, is the manufacturer of the dialysis products ...
Breaking Medicine News(10 mins):Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Multiplexed Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Severe infections with hospitalization after prostate biopsy rising in Sweden 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 3Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2
... WEST PALM BEACH, Fla., Aug. 25 For years, millions ... pantyhose to cover up unsightly varicose and spider veins. Now there,s ... Garden of Life,s ( www.gardeno f life.com ... clinical studies and millions of happy European women. , , ...
... ORLEANS, Aug. 25 Over 102,000 Americans are ... and a Slidell, Louisiana resident is making the most of his ... for the 2010 Transplant Olympics, twittering his progress, and furthering his ... a unique and personal level of hope and understanding by caring ...
... Study Suggests Division, Ambivalence and Hesitancy to Change; Demographics ... Aug. 25 Americans lack confidence that healthcare reform will deliver ... released today by the Thomson Reuters. , , ... a wide range of issues including the cost and quality of ...
... ... the aging eye , ... Francisco, CA (Vocus) August 25, 2009 -- EyeCare America, a national non-profit organization that provides ... a healthy aging eye in honor of September,s Save Your Sight Month., , , , ...
... ... of Honolulu are celebrating the fifth anniversary of their successful partnership by holding an ... ... healthcare education company, and Kapi,olani Community College of Honolulu are celebrating the fifth anniversary ...
... ... honest and forthright look at why Americans are overweight, overwhelmed, and confused, and ... ... (PRWEB) August 25, 2009 -- The question is not whether Americans are getting ...
Cached Medicine News:Health News:Garden of Life Launches Lovely Legs(TM) to Reduce Visible Signs of Varicose and Spider Veins 2Health News:Double Recipient Twitters Transplant Olympic Training and Tackles Nursing School 2Health News:Thomson Reuters Survey: Americans Skeptical that Healthcare Reform Will Improve Quality or Affordability 2Health News:Thomson Reuters Survey: Americans Skeptical that Healthcare Reform Will Improve Quality or Affordability 3Health News:EyeCare America Promotes Healthy Aging Tips During September's Save Your Sight Month 2Health News:EyeCare America Promotes Healthy Aging Tips During September's Save Your Sight Month 3Health News:EyeCare America Promotes Healthy Aging Tips During September's Save Your Sight Month 4Health News:Career Step and Kapi'olani Community College Celebrate Five Year Partnership 2Health News:The Naked Truth: Overweight, Overwhelmed and Confused 2
(Date:8/20/2014)... Breathe , the fastest growing online sleep apnea shopping destination ... received more than 4.5 million unique page views since the start ... many people are finding our blog and reading our articles," said ... making sleep apnea more widely known and hope that people continue ... news , troubleshooting advice , and new product launches ...
(Date:8/20/2014)... , Aug. 20, 2014  Quantum Materials ... diverse sets of patent families from Bayer Technology Services ... driver for Bayer AG of Leverkusen, ... acquired provide broad intellectual property protection for advances ... high-volume quantum dot (QD) manufacturing. In addition, the ...
(Date:8/19/2014)... BIRMINGHAM, Ala. , Aug. 19, 2014  The Alabama ... re-affirmed that patients can sue drug makers who mislead doctors ... cause harmful side‑effects.  The case is Weeks v. Wyeth, and ... drug makers in that same case last year. Heninger Garrison ... represent the patient in the case, Danny Weeks ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4
... The Food and Drug Administration (FDA) has recently issued ... a "natural sexual enhancer" that contains a hidden drug ... because of a label mix-up an infusion set that ... for pregnant women (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ...
... A state-of-the-art, eFlow Technology nebulizer (PARI Pharma GmbH) has ... (Mee-us), a 27-year-old orangutan, has what veterinarians believe to ... a substantial problem in both wild and zoo orangutans. ... also have some similarities to cystic fibrosis in people. ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: March 2011 2Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 2Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 3Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 4
The Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum....
... wavelength (532 nm and 940 nm) laser ... solution. This solid-state laser quickly and effectively ... vulgaris. VariLite offers the clinical versatility to ... deeper, larger vessels in a convenient, affordable ...
... PREMIUM SURGICLIP™ clip applier consists of an applier ... 15 or 20 titanium clips. , ,The ... or other tubular structure. As the handles of ... closed around the vessel or structure. As the ...
The LIGACLIP ERCA Endoscopic Rotating Multiple Clip Applier is intended for use on tubular structures or vessels wherever a metal ligating clip is indicated. The tissue being ligated should be consis...
Medicine Products: